KUALA LUMPUR (Sept 14): RHB Retail Research said Sunzen Biotech Bhd may be in the process of extending its rebound after it recently crossed above the 21-day simple moving average (SMA) line and holding above the 16.5 sen support level.
In a trading stocks note today, the research house said a positive bias may emerge above this point with resistance levels marked at 19 sen and 21.5 sen.
“A downside breach of 16.5 sen would invalidate this positive thesis,” it said.